文献速递糖尿病性腺与生殖内分泌

抗苗勒管激素水平与女性2型糖尿病风险

Anti-Müllerian hormone levels and risk of type 2 diabetes in women.
PubMed 文献 · Diabetologia · 2020-10-13

研究基于Doetinchem队列3293名20-59岁女性,重复测量血浆AMH,中位随访20年。发现基线年龄特异性AMH较低与2型糖尿病风险升高相关(HR T1vsT3 1.62,95%CI 1.06-2.48)。纵向分析未显示糖尿病组与非糖尿病组AMH轨迹有显著差异。

要点

  • 年龄特异性AMH最低三分位女性2型糖尿病风险是最高的1.62倍。
  • AMH轨迹在糖尿病与非糖尿病女性间无显著差异,可能因统计效能不足。
  • AMH或可作为女性生殖衰老与2型糖尿病关联的潜在生物标志物。

核心结论

  • 年龄特异性AMH水平较低与女性2型糖尿病风险升高相关。
  • 纵向分析未发现糖尿病组与非糖尿病组AMH轨迹有显著差异,可能因效能不足。

研究设计与样本

  • 前瞻性队列研究,来自Doetinchem队列,3293名女性,入组年龄20-59岁,每5年随访一次,共12460份血浆样本。

主要发现

  • 中位随访20年,163名女性发生2型糖尿病。
  • 基线年龄特异性AMH最低三分位与最高三分位相比,2型糖尿病风险HR为1.62(95%CI 1.06,2.48),趋势P=0.02。
  • AMH中间三分位与最高三分位相比,HR为1.24(95%CI 0.81,1.92)。
  • 预测的AMH轨迹提示糖尿病女性年轻时AMH较低,且下降速率较慢,但轨迹差异无统计学意义。

临床怎么用

  • 对于育龄期女性,低年龄特异性AMH水平可能提示2型糖尿病风险增加,可考虑纳入风险评估。
  • 目前证据尚不足以将AMH作为独立预测工具,需结合传统危险因素综合判断。

局限性

  • 纵向AMH轨迹分析可能因统计效能不足而未能检出显著差异。
  • 研究人群为20-59岁女性,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Given its role in ovarian follicle development, circulating anti-Müllerian hormone (AMH) is considered to be a marker of reproductive ageing. Although accelerated reproductive ageing has been associated with a higher risk of type 2 diabetes, research on the relationship between AMH and type 2 diabetes risk is scarce. Therefore, we aimed to investigate whether age-specific AMH levels and age-related AMH trajectories are associated with type 2 diabetes risk in women. METHODS: We measured AMH in repeated plasma samples from 3293 female participants (12,460 samples in total), aged 20-59 years at recruitment, from the Doetinchem Cohort Study, a longitudinal study with follow-up visits every 5 years. We calculated age-specific AMH tertiles at baseline to account for the strong AMH-age correlation. Cox proportional hazards models adjusted for confounders were used to assess the association between baseline age-specific AMH tertiles and incident type 2 diabetes. We applied linear mixed models to compare age-related AMH trajectories for women who developed type 2 diabetes with trajectories for women who did not develop diabetes. RESULTS: During a median follow-up of 20 years, 163 women developed type 2 diabetes. Lower baseline age-specific AMH levels were associated with a higher type 2 diabetes risk (HRT2vsT3 1.24 [95% CI 0.81, 1.92]; HRT1vsT3 1.62 [95% CI 1.06, 2.48]; ptrend = 0.02). These findings seem to be supported by predicted AMH trajectories, which suggested that plasma AMH levels were lower at younger ages in women who developed type 2 diabetes compared with women who did not. The trajectories also suggested that AMH levels declined at a slower rate in women who developed type 2 diabetes, although differences in trajectories were not statistically significant. CONCLUSIONS/INTERPRETATION: We observed that lower age-specific AMH levels were associated with a higher risk of type 2 diabetes in women. Longitudinal analyses did not show clear evidence of differing AMH trajectories between women who developed type 2 diabetes compared with women who did not, possibly because these analyses were underpowered. Further research is needed to investigate whether AMH is part of the biological mechanism explaining the association between reproductive ageing and type 2 diabetes. Graphical abstract.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Verdiesen RMG, Onland-Moret NC, van Gils CH, et al. Anti-Müllerian hormone levels and risk of type 2 diabetes in women. Diabetologia. 2020. PMID: 33048171. doi:10.1007/s00125-020-05302-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。